Paclitaxel Induced B7-H1 Expression in Cancer Cells via the MAPK Pathway

REFERENCES

• Blank C, Kuball J, Voelkl S, Wiendl H, Becker B, Walter B et al. Block-ade of PD-Li (B7-H1) augments human tumor-specific T cell responses in vitro. Int J Cancer 2006; 119 (2): 317-327.
   Google Scholar
• Hirano F, Kaneko K, Tamura H, Dong H, Wang S, Ichikawa M et al. Blockade of B7-H1 and PD-1 by monoclonal antibodies potentiates cancer therapeutic immunity. Cancer Res 2005; 65 (3): 1089-1096.
   Google Scholar
• Dong H, Chen L. B7-H1 pathway and its role in the evasion of tumor immunity. J Molecular Med (Berlin, Germany) 2003; 81 (5): 281–287.
   PubMed Web of Science ®Google Scholar
• Dong H, Zhu G, Tamada K, Chen L. B7-H1, a third member of the B7 family, co-stimulates T-cell proliferation and interleukin-10 secretion. Nature Med 1999; 5 (12): 1365–1369.
   PubMed Web of Science ®Google Scholar
• ZOU W, Chen L. Inhibitory B7-family molecules in the tumour mi-croenvironment. Nature Rev 2008; 8 (6): 467–477.
   Web of Science ®Google Scholar
• Lukens JR, Cruise MW, Lassen MG, Hahn YS. Blockade of PD-1/137-H1 interaction restores effector CD8+ T cell responses in a hepatitis C virus core murine model. J Immunol 2008; 180 (7): 4875–4884.
   PubMed Web of Science ®Google Scholar
• Curiel TJ, Wei S, Dong H, Alvarez X, Cheng P, Mottram P et al. Block-ade of B7-H1 improves myeloid dendritic cell-mediated antitumor immunity. Nature MEd 2003; 9 (5): 562-567.
   Google Scholar
• Dong H, Strome SE, Salomao DR, Tamura H, Hirano F, Flies DB et al. Tumor-associated B7-h1 promotes T-cell apoptosis: a potential mecha-nism of immune evasion. Nature Med 2002; 8 (8): 793-800.
   Google Scholar
• Mazanet MM, Hughes CC. B7-H1 is expressed by human endothelial cells and suppresses T cell cytokine synthesis. J Immunol 2002; 169 (7): 3581–3588.
   PubMed Web of Science ®Google Scholar
• Schreiner B, Mitsdoerffer M, Kieseier BC, Chen L, Hartung HP, Weller M et al. Interferon-beta enhances monocyte and dendritic cell ex-pression of B7-H1 (PD-L1), a strong inhibitor of autologous T-cell activa-tion: relevance for the immune modulatory effect in multiple sclerosis. J Neuroimmunol 2004; 155 (1-2):172-182.
   Google Scholar
• Muhlbauer M, Fleck M, Schutz C, Weiss T, Froh M, Blank C et al. PD-Li is induced in hepatocytes by viral infection and by interferon-alpha and - gamma and mediates T cell apoptosis. J Hepatol 2006; 45 (4): 520–528.
   Google Scholar
• Thompson RH, Kuntz SM, Leibovich BC, Dong Lohse CM, Webster WS et al. Tumor B7-H1 is associated with poor prognosis in renal cell carcinoma patients with long-term follow-up. Cancer Res 2006; 66 (7): 3381-3385.
   Google Scholar
• Ghebeh H, Mohammed S, Al-Omair A, Qattan A, Lehe C, Al-Qudaihi G et al. The B7-H1 (PD-L1) T lymphocyte-inhibitory molecule is expressed in breast cancer patients with infiltrating ductal carcinoma: correlation with important high-risk prognostic factors. Neoplasia (New York, NY 2006; 8 (3): 190-198.
   Google Scholar
• Iwai Y, Ishida M, Tanaka Y, Okazaki T, Honjo T, Minato N. Involvement of PD-Li on tumor cells in the escape from host immune system and tumor immunotherapy by PD-Li blockade. Proc Natl Acad Sci USA 2002; 99 (19): 12293–12297.
   PubMed Web of Science ®Google Scholar
• Zhang P, Su DM, Liang M, Fu J. Chemopreventive agents induce programmed death-l-ligand 1 (PD-L1) surface expression in breast cancer cells and promote PD-Li-mediated T cell apoptosis. Molec Immunol 2008; 45 (5): 1470–1476.
   PubMed Web of Science ®Google Scholar
• Ghebeh H, Lehe C, Barhoush E, Al-Romaih K, Tulbah A, Al-Alwan M et al. Doxorubicin downregulates cell surface B7-H1 expression and up-regulates its nuclear expression in breast cancer cells: role of B7-H1 as an anti-apoptotic molecule. Breast Cancer Res; 12 (4):R48.
   Google Scholar
• Crane CA, Panner A, Murray JC, Wilson SP, Xu H, Chen L et al. PI(3) kinase is associated with a mechanism of immunoresistance in breast and prostate cancer. Oncogene 2009; 28 (2): 306-312.
   Google Scholar
• Karakhanova S, Meisel S, Ring S, Mahnke K, Enk AFL ERK/p38 MAP-kinases and PI3K are involved in the differential regulation of B7-H1 expression in DC subsets. Eur J Immunol 2009; 40 (1): 254–266.
   Web of Science ®Google Scholar
• Xu R, Sato N, Yanai K, Akiyoshi T, Nagai S, Wada J et al. Enhance-ment of paclitaxel-induced apoptosis by inhibition of mitogen-activated pro-tein kinase pathway in colon cancer cells. Anticancer Res 2009; 29 (1): 261–270.
   Google Scholar
• Yamamoto R, Nishikori M, Tashima M, Sakai T, Ichinohe T, Takaori-Kondo A et al. B7-H1 expression is regulated by MEK/ERK signaling path-way in anaplastic large cell lymphoma and Hodgkin lymphoma. Cancer Sci 2009; 100 (11): 2093-2100.
   Google Scholar
• Isomura I, Shintani Y, Yasuda Y, Tsujimura K, Morita A. Induction of regulatory dendritic cells by topical application of NF-kappaB decoy oligodeoxynucleotides. Immunol Lett 2008; 119 (1-2): 49–56.
   PubMed Web of Science ®Google Scholar
• Paoletti X, Oba K, Burzykowski T, Michiels S, Ohashi Y, Pignon JP et al. Benefit of adjuvant chemotherapy for resectable gastric cancer: a meta-analysis. JAMA; 303 (17): 1729–1737.
   PubMed Web of Science ®Google Scholar
• Zindl CL, Chaplin DD. Immunology. Tumor immune evasion. Science 2010; 328 (5979): 697–698.
   Google Scholar
• Zozulya AL, Order S, Fabry Z, Sandor M, Wiendl H. The level of B7 homologue 1 expression on brain DC is decisive for CD8 Treg cell recruit-ment into the CNS during EAE. Eur J Immunol 2009; 39 (6): 1536–1543.
   PubMed Web of Science ®Google Scholar
• Waisman A, Yogev N. B7-H1 and CD8+ Treg: the enigmatic role of B7-H1 in peripheral tolerance. Eur J Immunol 2009; 39 (6): 1448–1451.
   PubMed Web of Science ®Google Scholar
• Archibald DJ, Neff BA, Voss SG, Splinter PL, Driscoll CL, Link MJ et al. B7-H1 expression in vestibular schwannomas. Otol Neuroto1; 31 (6): 991-997.
   Google Scholar
• Wang L, Ma Q, Chen X, Guo K, Li J, Zhang M. Clinical significance of b7-hl and 67-1 expressions in pancreatic carcinoma. World J Surg; 34 (5): 1059-1065.
   Google Scholar
• Wei J, Barr J, Kong LY, Wang Y, Wu A, Sharma AK et al. Glioma-associated cancer-initiating cells induce immunosuppression. Clin Cancer Res; 16 (2): 461-473.
   Google Scholar
• Ye Y, Zhou L, Xie X, Jiang G, Xie H, Zheng S. Interaction of B7-H1 on intrahepatic cholangiocarcinoma cells with PD-1 on tumor-infiltrating T cells as a mechanism of immune evasion. J Surg Oncol 2009; 100 (6): 500–504.
   PubMed Web of Science ®Google Scholar
• Strome SE, Dong H, Tamura H, Voss SG, Flies DB, Tamada K et al. B7-H1 blockade augments adoptive T-cell immunotherapy for squamous cell carcinoma. Cancer Res 2003; 63 (19): 6501-6505.
   Google Scholar
• Nomi T, Sho M, Akahori T, Hamada K, Kubo A, Kanehiro H et al. Clinical significance and therapeutic potential of the programmed death-1 lig-and/programmed death-1 pathway in human pancreatic cancer. Clin Cancer Res 2007; 13 (7): 2151-2157.
   Google Scholar
• Nakanishi J, Wada Y, Matsumoto K, Azuma M, Kikuchi K, Ueda S. Overexpression of B7-H1 (PD-L1) significantly associates with tumor grade and postoperative prognosis in human urothelial cancers. Cancer Immunol Immunother 2007; 56 (8): 1173–1182.
   PubMed Web of Science ®Google Scholar
• Azuma T, Yao S, Zhu G, Flies AS, Flies SJ, Chen L. B7-H1 is a ubiq-uitous antiapoptotic receptor on cancer cells. Blood 2008; 111 (7): 3635–3643.
   PubMed Web of Science ®Google Scholar